Advertisement
UK markets open in 2 hours 32 minutes

  • NIKKEI 225

    37,903.65
    +275.17 (+0.73%)
     

  • HANG SENG

    17,626.75
    +342.21 (+1.98%)
     

  • CRUDE OIL

    83.85
    +0.28 (+0.34%)
     

  • GOLD FUTURES

    2,347.10
    +4.60 (+0.20%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • Bitcoin GBP

    51,468.36
    +160.33 (+0.31%)
     

  • CMC Crypto 200

    1,386.62
    +4.05 (+0.29%)
     

  • NASDAQ Composite

    15,611.76
    -100.99 (-0.64%)
     

  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     
Stocks:

Trending tickers

Microsoft, Alphabet, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's

Smith & Nephew buoyed by sports medicine but China weak

Reuters - UK Focus

LONDON, July 28 (Reuters) - Smith & Nephew (LSE: SN.L - news) , Europe's biggest maker of artificial knees and hips, reported a 2 percent rise in second-quarter revenue on Thursday, helped by good growth in its sports medicine joint repair business.

But demand for its products in China and the Gulf States remained weak.

Revenue of $1.19 billion, which was broadly in line with analyst expectations, generated trading profit down 3 percent at $483 million. (Reporting by Ben Hirschler; editing by Susan Thomas)